DIGITAL TECHNOLOGIES IN DIABETES MANAGEMENT: THE ROLE OF CONTINUOUS GLUCOSE MONITORING AND ARTIFICIAL INTELLIGENCE IN MODERN ENDOCRINOLOGY
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5663Keywords:
Artificial Intelligence, Continuous Glucose Monitoring, Diabetes Management, Digital Health, Telemedicine, Wearable TechnologiesAbstract
The ongoing development of digital technologies, when used appropriately in diabetes care, has a significant impact on the management of patients with diabetes. New technologies enable the monitoring and adjustment of treatment in patients without the need for face-to-face appointments. The aim of this review is to discuss the role of continuous glucose monitoring, artificial intelligence, wearables, mobile applications and telemedicine in the development of diabetes care. Their clinical, organisational and social significance has been analysed. This is a review article based on publications from major biomedical databases.
Reviewed articles provide evidence that continuous glucose monitoring is more accurate for assessing blood glucose levels than traditional glucose or HbA1c measurements. Artificial intelligence can be used to predict fluctuations in blood glucose levels and improve the personalization of clinical decisions. It has been shown to be particularly effective when combined with automated insulin delivery systems. Mobile devices and apps, as well as telemedicine, can increase patients’ interest in their own health and, consequently, their involvement in the treatment process; however, their value depends on the quality of the collected data, interoperability, clinical usability, and the ability of healthcare professionals to understand the generated reports. The use of digital tools is associated with cyber threats regarding data privacy, as well as inequalities in access to healthcare and trust in technology among patients. Future research should cover long-term effectiveness, safety, equitable access, and the methods of implementing this technology into everyday patient care.
References
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., Shaw, J. E., Bright, D., Williams, R., & IDF Diabetes Atlas Committee. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes federation Diabetes atlas, 9th edition. Diabetes Research and Clinical Practice, 157, 107843. https://doi.org/10.1016/j.diabres.2019.107843
Saeedi, P., Salpea, P., Karuranga, S., Petersohn, I., Malanda, B., Gregg, E. W., Unwin, N., Wild, S. H., & Williams, R. (2020). Mortality attributable to diabetes in 20-79 years old adults. 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes research and clinical practice, 162, 108086. https://doi.org/10.1016/j.diabres.2020.108086
Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews. Endocrinology, 14(2), 88–98. https://doi.org/10.1038/nrendo.2017.151
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27(5), 1047–1053. https://doi.org/10.2337/diacare.27.5.1047
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018). IDF Diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice, 138, 271–281. https://doi.org/10.1016/j.diabres.2018.02.023
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., Toschi, E., Wolpert, H., Price, D., & DIAMOND Study Group. (2017). Effect of continuous glucose monitoring on glycemic control in adults with type 1 Diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA, 317(4), 371–378. https://doi.org/10.1001/jama.2016.19975
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., Cobelli, C., Dassau, E., DeVries, J. H., Donaghue, K. C., Dovc, K., Doyle, F. J., 3rd, Garg, S., Grunberger, G., Heller, S., Heinemann, L., … Phillip, M. (2019). Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International consensus on time in range. Diabetes Care, 42(8), 1593–1603. https://doi.org/10.2337/dci19-0028
Heinemann, L., Freckmann, G., Ehrmann, D., Faber-Heinemann, G., Guerra, S., Waldenmaier, D., & Hermanns, N. (2018). Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): A multicentre, randomised controlled trial. Lancet (London, England), 391(10128), 1367–1377. https://doi.org/10.1016/S0140-6736(18)30297-6
Klonoff, D. C. (2005). Continuous glucose monitoring: Roadmap for 21st century diabetes therapy. Diabetes Care, 28(5), 1231–1239. https://doi.org/10.2337/diacare.28.5.1231
American Diabetes Association Professional Practice Committee. (2024). 2. Diagnosis and classification of Diabetes: Standards of care in Diabetes-2024. Diabetes Care, 47(Suppl 1), S20–S42. https://doi.org/10.2337/dc24-S002
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type 1 diabetes. Lancet (London, England), 383(9911), 69–82. https://doi.org/10.1016/S0140-6736(13)60591-7
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., Simonson, D. C., Testa, M. A., & Weiss, R. (2015). Type 2 diabetes mellitus. Nature Reviews. Disease Primers, 1, 15019. https://doi.org/10.1038/nrdp.2015.19
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., Skyler, J. S., Snoek, F. J., Weinstock, R. S., & Peters, A. L. (2021). The management of type 1 diabetes in adults. A consensus report by the American Diabetes association (ADA) and the European association for the study of Diabetes (EASD). Diabetologia, 64(12), 2609–2652. https://doi.org/10.1007/s00125-021-05568-3
World Health Organization. (2019). Classification of diabetes mellitus. World Health Organization. https://iris.who.int/handle/10665/325182
Saltiel, A. R., & Kahn, C. R. (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414(6865), 799–806. https://doi.org/10.1038/414799a
Tokarz, V. L., MacDonald, P. E., & Klip, A. (2018). The cell biology of systemic insulin function. The Journal of Cell Biology, 217(7), 2273–2289. https://doi.org/10.1083/jcb.201802095
Samuel, V. T., & Shulman, G. I. (2012). Mechanisms for insulin resistance: Common threads and missing links. Cell, 148(5), 852–871. https://doi.org/10.1016/j.cell.2012.02.017
Defronzo, R. A. (2009). Banting lecture. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes, 58(4), 773–795. https://doi.org/10.2337/db09-9028
Wilcox, G. (2005). Insulin and insulin resistance. The Clinical Biochemist. Reviews, 26(2), 19–39.
Gerich, J. E. (2010). Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: Therapeutic implications. Diabetic Medicine : a Journal of the British Diabetic Association, 27(2), 136–142. https://doi.org/10.1111/j.1464-5491.2009.02894.x
Dalga, D., Verissimo, T., & de Seigneux, S. (2023). Gluconeogenesis in the kidney: In health and in chronic kidney disease. Clinical Kidney Journal, 16(8), 1249–1257. https://doi.org/10.1093/ckj/sfad046
Freckmann, G., Schmid, C., Baumstark, A., Pleus, S., Link, M., & Haug, C. (2012). System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197. Journal of Diabetes Science and Technology, 6(5), 1060–1075. https://doi.org/10.1177/193229681200600510
Tonyushkina, K., & Nichols, J. H. (2009). Glucose meters: A review of technical challenges to obtaining accurate results. Journal of Diabetes Science and Technology, 3(4), 971–980. https://doi.org/10.1177/193229680900300446
American Diabetes Association Professional Practice Committee. (2024). 6. Glycemic goals and hypoglycemia: Standards of care in Diabetes-2024. Diabetes Care, 47(Suppl 1), S111–S125. https://doi.org/10.2337/dc24-S006
Little, R. R., & Sacks, D. B. (2009). HbA1c: How do we measure it and what does it mean?. Current Opinion in Endocrinology, Diabetes, and Obesity, 16(2), 113–118. https://doi.org/10.1097/MED.0b013e328327728d
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & A1c-Derived Average Glucose Study Group. (2008). Translating the A1C assay into estimated average glucose values. Diabetes Care, 31(8), 1473–1478. https://doi.org/10.2337/dc08-0545
Monnier, L., Colette, C., & Owens, D. R. (2008). Glycemic variability: The third component of the dysglycemia in diabetes. Is it important? How to measure it?. Journal of Diabetes Science and Technology, 2(6), 1094–1100. https://doi.org/10.1177/193229680800200618
Service, F. J. (2013). Glucose variability. Diabetes, 62(5), 1398–1404. https://doi.org/10.2337/db12-1396
Rodbard, D. (2016). Continuous glucose monitoring: A review of successes, challenges, and opportunities. Diabetes Technology & Therapeutics, 18 Suppl 2(Suppl 2), S3–S13. https://doi.org/10.1089/dia.2015.0417
Heller, A., & Feldman, B. (2008). Electrochemical glucose sensors and their applications in diabetes management. Chemical Reviews, 108(7), 2482–2505. https://doi.org/10.1021/cr068069y
Bruen, D., Delaney, C., Florea, L., & Diamond, D. (2017). Glucose sensing for Diabetes monitoring: Recent developments. Sensors (Basel, Switzerland), 17(8), 1866. https://doi.org/10.3390/s17081866
Vaddiraju, S., Burgess, D. J., Tomazos, I., Jain, F. C., & Papadimitrakopoulos, F. (2010). Technologies for continuous glucose monitoring: Current problems and future promises. Journal of Diabetes Science and Technology, 4(6), 1540–1562. https://doi.org/10.1177/193229681000400632
Chen, C., Zhao, X. L., Li, Z. H., Zhu, Z. G., Qian, S. H., & Flewitt, A. J. (2017). Current and emerging technology for continuous glucose monitoring. Sensors (Basel, Switzerland), 17(1), 182. https://doi.org/10.3390/s17010182
Dagdelen, S., Deyneli, O., Dinccag, N., Ilkova, H., Osar Siva, Z., Yetkin, I., & Yilmaz, T. (2022). Expert panel recommendations for use of standardized glucose reporting system based on standardized glucometrics plus visual ambulatory glucose profile (AGP) data in clinical practice. Frontiers in Endocrinology, 12, 663222. https://doi.org/10.3389/fendo.2021.663222
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015). The performance and usability of a Factory-Calibrated flash glucose monitoring system. Diabetes Technology & Therapeutics, 17(11), 787–794. https://doi.org/10.1089/dia.2014.0378
Shah, V. N., Laffel, L. M., Wadwa, R. P., & Garg, S. K. (2018). Performance of a Factory-Calibrated Real-Time continuous glucose monitoring system utilizing an automated sensor applicator. Diabetes Technology & Therapeutics, 20(6), 428–433. https://doi.org/10.1089/dia.2018.0143
Ólafsdóttir, A. F., Attvall, S., Sandgren, U., Dahlqvist, S., Pivodic, A., Skrtic, S., Theodorsson, E., & Lind, M. (2017). A clinical trial of the accuracy and treatment experience of the flash glucose monitor FreeStyle libre in adults with type 1 Diabetes. Diabetes Technology & Therapeutics, 19(3), 164–172. https://doi.org/10.1089/dia.2016.0392
Reiterer, F., Polterauer, P., Schoemaker, M., Schmelzeisen-Redecker, G., Freckmann, G., Heinemann, L., & Del Re, L. (2017). Significance and reliability of MARD for the accuracy of CGM systems. Journal of Diabetes Science and Technology, 11(1), 59–67. https://doi.org/10.1177/1932296816662047
Wadwa, R. P., Laffel, L. M., Shah, V. N., & Garg, S. K. (2018). Accuracy of a Factory-Calibrated, Real-Time continuous glucose monitoring system during 10 days of use in youth and adults with Diabetes. Diabetes Technology & Therapeutics, 20(6), 395–402. https://doi.org/10.1089/dia.2018.0150
Hughes, M. S., & Levy, C. J. (2025). The future of automated insulin delivery systems. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 31(9), 1162–1170. https://doi.org/10.1016/j.eprac.2025.05.752
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., Ahlén, E., Nyström, T., & Hellman, J. (2017). Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 Diabetes treated with multiple daily insulin injections: The GOLD randomized clinical trial. JAMA, 317(4), 379–387. https://doi.org/10.1001/jama.2016.19976
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., Davis, G., Kruger, D., Bhargava, A., Young, L., McGill, J. B., Aleppo, G., Nguyen, Q. T., Orozco, I., Biggs, W., Lucas, K. J., … MOBILE Study Group. (2021). Effect of continuous glucose monitoring on glycemic control in patients with type 2 Diabetes treated with basal insulin: A randomized clinical trial. JAMA, 325(22), 2262–2272. https://doi.org/10.1001/jama.2021.7444
Aleppo, G., Ruedy, K. J., Riddlesworth, T. D., Kruger, D. F., Peters, A. L., Hirsch, I., Bergenstal, R. M., Toschi, E., Ahmann, A. J., Shah, V. N., Rickels, M. R., Bode, B. W., Philis-Tsimikas, A., Pop-Busui, R., Rodriguez, H., Eyth, E., Bhargava, A., Kollman, C., Beck, R. W., & REPLACE-BG Study Group. (2017). REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with Well-Controlled type 1 Diabetes. Diabetes Care, 40(4), 538–545. https://doi.org/10.2337/dc16-2482
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016). Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: A multicentre, non-masked, randomised controlled trial. Lancet (London, England), 388(10057), 2254–2263. https://doi.org/10.1016/S0140-6736(16)31535-5
van Beers, C. A., DeVries, J. H., Kleijer, S. J., Smits, M. M., Geelhoed-Duijvestijn, P. H., Kramer, M. H., Diamant, M., Snoek, F. J., & Serné, E. H. (2016). Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): A randomised, open-label, crossover trial. The lancet. Diabetes & Endocrinology, 4(11), 893–902. https://doi.org/10.1016/S2213-8587(16)30193-0
Advani, A. (2020). Positioning time in range in diabetes management. Diabetologia, 63(2), 242–252. https://doi.org/10.1007/s00125-019-05027-0
Lu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., & Jia, W. (2018). Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 Diabetes. Diabetes Care, 41(11), 2370–2376. https://doi.org/10.2337/dc18-1131
Beck, R. W., Bergenstal, R. M., Riddlesworth, T. D., Kollman, C., Li, Z., Brown, A. S., & Close, K. L. (2019). Validation of time in range as an outcome measure for Diabetes clinical trials. Diabetes Care, 42(3), 400–405. https://doi.org/10.2337/dc18-1444
Pérez-Gandía, C., Facchinetti, A., Sparacino, G., Cobelli, C., Gómez, E. J., Rigla, M., de Leiva, A., & Hernando, M. E. (2010). Artificial neural network algorithm for online glucose prediction from continuous glucose monitoring. Diabetes Technology & Therapeutics, 12(1), 81–88. https://doi.org/10.1089/dia.2009.0076
Kavakiotis, I., Tsave, O., Salifoglou, A., Maglaveras, N., Vlahavas, I., & Chouvarda, I. (2017). Machine learning and data mining methods in Diabetes research. Computational and Structural Biotechnology Journal, 15, 104–116. https://doi.org/10.1016/j.csbj.2016.12.005
Georga, E. I., Protopappas, V. C., Ardigo, D., Marina, M., Zavaroni, I., Polyzos, D., & Fotiadis, D. I. (2013). Multivariate prediction of subcutaneous glucose concentration in type 1 diabetes patients based on support vector regression. IEEE Journal of Biomedical and Health Informatics, 17(1), 71–81. https://doi.org/10.1109/TITB.2012.2219876
Contreras, I., & Vehi, J. (2018). Artificial intelligence for Diabetes management and decision support: Literature review. Journal of Medical Internet Research, 20(5), e10775. https://doi.org/10.2196/10775
Zarkogianni, K., Litsa, E., Mitsis, K., Wu, P. Y., Kaddi, C. D., Cheng, C. W., Wang, M. D., & Nikita, K. S. (2015). A review of emerging technologies for the management of Diabetes mellitus. IEEE Transactions on Bio-medical Engineering, 62(12), 2735–2749. https://doi.org/10.1109/TBME.2015.2470521
Daskalaki, E., Prountzou, A., Diem, P., & Mougiakakou, S. G. (2012). Real-time adaptive models for the personalized prediction of glycemic profile in type 1 diabetes patients. Diabetes Technology & Therapeutics, 14(2), 168–174. https://doi.org/10.1089/dia.2011.0093
Oviedo, S., Vehí, J., Calm, R., & Armengol, J. (2017). A review of personalized blood glucose prediction strategies for T1DM patients. International Journal for Numerical Methods in Biomedical Engineering, 33(6), 10.1002/cnm.2833. https://doi.org/10.1002/cnm.2833
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016). Safety of a hybrid Closed-Loop insulin delivery system in patients with type 1 Diabetes. JAMA, 316(13), 1407–1408. https://doi.org/10.1001/jama.2016.11708
Topol, E. (2019). Deep medicine: How artificial intelligence can make healthcare human again. Basic Books.
Rodbard, D. (2009). Interpretation of continuous glucose monitoring data: Glycemic variability and quality of glycemic control. Diabetes Technology & Therapeutics, 11 Suppl 1, S55–S67. https://doi.org/10.1089/dia.2008.0132
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., Beck, R., Bosi, E., Buckingham, B., Cobelli, C., Dassau, E., Doyle, F. J., 3rd, Heller, S., Hovorka, R., Jia, W., Jones, T., … Phillip, M. (2017). International consensus on use of continuous glucose monitoring. Diabetes Care, 40(12), 1631–1640. https://doi.org/10.2337/dc17-1600
Facchinetti, A. (2016). Continuous glucose monitoring sensors: Past, present and future algorithmic challenges. Sensors (Basel, Switzerland), 16(12), 2093. https://doi.org/10.3390/s16122093
Sparacino, G., Facchinetti, A., & Cobelli, C. (2010). "Smart" continuous glucose monitoring sensors: On-line signal processing issues. Sensors (Basel, Switzerland), 10(7), 6751–6772. https://doi.org/10.3390/s100706751
Patel, S., Park, H., Bonato, P., Chan, L., & Rodgers, M. (2012). A review of wearable sensors and systems with application in rehabilitation. Journal of Neuroengineering and Rehabilitation, 9, 21. https://doi.org/10.1186/1743-0003-9-21
Li, X., Dunn, J., Salins, D., Zhou, G., Zhou, W., Schüssler-Fiorenza Rose, S. M., Perelman, D., Colbert, E., Runge, R., Rego, S., Sonecha, R., Datta, S., McLaughlin, T., & Snyder, M. P. (2017). Digital health: Tracking physiomes and activity using wearable biosensors reveals useful Health-Related information. PLoS Biology, 15(1), e2001402. https://doi.org/10.1371/journal.pbio.2001402
Dunn, J., Runge, R., & Snyder, M. (2018). Wearables and the medical revolution. Personalized Medicine, 15(5), 429–448. https://doi.org/10.2217/pme-2018-0044
Piwek, L., Ellis, D. A., Andrews, S., & Joinson, A. (2016). The rise of consumer health wearables: Promises and barriers. PLoS Medicine, 13(2), e1001953. https://doi.org/10.1371/journal.pmed.1001953
Smuck, M., Odonkor, C. A., Wilt, J. K., Schmidt, N., Swiernik, M. A., & …. (2021). The emerging clinical role of wearables: Factors for successful implementation in healthcare. npj Digital Medicine, 4, 45. https://doi.org/10.1038/s41746-021-00418-3
Wu, Y., Yao, X., Vespasiani, G., Nicolucci, A., Dong, Y., Kwong, J., Li, L., Sun, X., Tian, H., & Li, S. (2017). Mobile App-Based interventions to support Diabetes Self-Management: A systematic review of randomized controlled trials to identify functions associated with glycemic efficacy. JMIR mHealth and uHealth, 5(3), e35. https://doi.org/10.2196/mhealth.6522
Veazie, S., Winchell, K., Gilbert, J., Paynter, R., Ivlev, I., Eden, K. B., Nussbaum, K., Weiskopf, N., Guise, J. M., & Helfand, M. (2018). Rapid evidence review of mobile applications for self-management of Diabetes. Journal of General Internal Medicine, 33(7), 1167–1176. https://doi.org/10.1007/s11606-018-4410-1
Hou, C., Carter, B., Hewitt, J., Francisa, T., & Mayor, S. (2016). Do mobile phone applications improve glycemic control (HbA1c) in the self-management of Diabetes? A systematic review, meta-analysis, and GRADE of 14 randomized trials. Diabetes Care, 39(11), 2089–2095. https://doi.org/10.2337/dc16-0346
Bonoto, B. C., de Araújo, V. E., Godói, I. P., de Lemos, L. L., Godman, B., Bennie, M., Diniz, L. M., & Junior, A. A. (2017). Efficacy of mobile apps to support the care of patients with Diabetes mellitus: A systematic review and Meta-Analysis of randomized controlled trials. JMIR mHealth and uHealth, 5(3), e4. https://doi.org/10.2196/mhealth.6309
Quinn, C. C., Clough, S. S., Minor, J. M., Lender, D., Okafor, M. C., & Gruber-Baldini, A. (2008). WellDoc mobile diabetes management randomized controlled trial: Change in clinical and behavioral outcomes and patient and physician satisfaction. Diabetes Technology & Therapeutics, 10(3), 160–168. https://doi.org/10.1089/dia.2008.0283
Marcolino, M. S., Maia, J. X., Alkmim, M. B., Boersma, E., & Ribeiro, A. L. (2013). Telemedicine application in the care of diabetes patients: Systematic review and meta-analysis. PloS One, 8(11), e79246. https://doi.org/10.1371/journal.pone.0079246
Tchero, H., Kangambega, P., Briatte, C., Brunet-Houdard, S., Retali, G. R., & Rusch, E. (2019). Clinical effectiveness of telemedicine in Diabetes mellitus: A Meta-Analysis of 42 randomized controlled trials. Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association, 25(7), 569–583. https://doi.org/10.1089/tmj.2018.0128
Lee, S. W. H., Ooi, L., & Lai, Y. K. (2017). Telemedicine for the management of glycemic control and clinical outcomes of type 1 Diabetes mellitus: A systematic review and Meta-Analysis of randomized controlled studies. Frontiers in Pharmacology, 8, 330. https://doi.org/10.3389/fphar.2017.00330
Bashshur, R. L., Shannon, G. W., Smith, B. R., Alverson, D. C., Antoniotti, N., Barsan, W. G., Bashshur, N., Brown, E. M., Coye, M. J., Doarn, C. R., Ferguson, S., Grigsby, J., Krupinski, E. A., Kvedar, J. C., Linkous, J., Merrell, R. C., Nesbitt, T., Poropatich, R., Rheuban, K. S., Sanders, J. H., … Yellowlees, P. (2014). The empirical foundations of telemedicine interventions for chronic disease management. Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association, 20(9), 769–800. https://doi.org/10.1089/tmj.2014.9981
Vidal-Alaball, J., Acosta-Roja, R., Pastor Hernández, N., Sanchez Luque, U., Morrison, D., Narejos Pérez, S., Perez-Llano, J., Salvador Vèrges, A., & López Seguí, F. (2020). Telemedicine in the face of the COVID-19 pandemic. Atencion Primaria, 52(6), 418–422. https://doi.org/10.1016/j.aprim.2020.04.003
Shomali, M., Mora, P., Aleppo, G., Peeples, M., Kumbara, A., MacLeod, J., & Iyer, A. (2024). The critical elements of digital health in diabetes and cardiometabolic care. Frontiers in Endocrinology, 15, 1469471. https://doi.org/10.3389/fendo.2024.1469471
American Diabetes Association Professional Practice Committee. (2025). 7. Diabetes technology: Standards of care in Diabetes-2025. Diabetes Care, 48(1 Suppl 1), S146–S166. https://doi.org/10.2337/dc25-S007
Aleppo, G., Gal, R. L., Raghinaru, D., Kruger, D., Beck, R. W., Bergenstal, R. M., Cushman, T., Hood, K. K., Johnson, M. L., McArthur, T., Bradshaw, A., Olson, B. A., Oser, S. M., Oser, T. K., Kollman, C., & Weinstock, R. S. (2023). Comprehensive telehealth model to support Diabetes Self-Management. JAMA Network Open, 6(10), e2336876. https://doi.org/10.1001/jamanetworkopen.2023.36876
Reddy, S., Wu, C. C., José, A., Hsieh, J. L., & Rautela, S. D. (2023). Personalized virtual care using continuous glucose monitoring in adults with type 2 Diabetes treated with less intensive therapies. Clinical Diabetes : a Publication of the American Diabetes Association, 41(3), 452–457. Advance online publication. https://doi.org/10.2337/cd22-0128
Toschi, E., Adam, A., Frimpong, N., Hurlbert, R., Slyne, C., Laffel, L., & Munshi, M. (2024). Hybrid care model: Combining telemedicine and office visits for diabetes management in older adults with type 1 diabetes. Medical Research Archives, 12(9), 5728. https://doi.org/10.18103/mra.v12i9.5728
Jendle, J., Adolfsson, P., Choudhary, P., Dovc, K., Fleming, A., Klonoff, D. C., Mader, J. K., Oliver, N., Sherr, J. L., Šoupal, J., & Heinemann, L. (2024). A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective. Diabetologia, 67(2), 236–245. https://doi.org/10.1007/s00125-023-06049-5
Bertolazzi, A., Marzęda-Młynarska, K., Kięczkowska, J., & Zanier, M. L. (2024). Datafication of care: Security and privacy issues with health technology for people with Diabetes. Societies, 14(9), 163. https://doi.org/10.3390/soc14090163
World Health Organization. (2021). Ethics and governance of artificial intelligence for health: WHO guidance. https://www.who.int/publications/i/item/9789240029200
Materne, S., Canali, S., & Chiffi, D. (2025). Trust in medical AI: The case of mHealth Diabetes apps. Journal of Evaluation in Clinical Practice, 31(5), e70216. https://doi.org/10.1111/jep.70216
U.S. Food and Drug Administration. (2023, September). Cybersecurity in medical devices: Quality system considerations and content of premarket submissions. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cybersecurity-medical-devices-quality-system-considerations-and-content-premarket-submissions
European Commission. (n.d.). Artificial intelligence in healthcare. Retrieved April 24, 2026, from https://health.ec.europa.eu/ehealth-digital-health-and-care/artificial-intelligence-healthcare_en
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., Amiel, S. A., Bally, L., Beck, R. W., Biester, S., Biester, T., Blanchette, J. E., Bosi, E., Boughton, C. K., Breton, M. D., Brown, S. A., … Battelino, T. (2023). Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocrine Reviews, 44(2), 254–280. https://doi.org/10.1210/endrev/bnac022
Campanella, S., Paragliola, G., Cherubini, V., Pierleoni, P., & Palma, L. (2024). Towards personalized AI-Based Diabetes therapy: A review. IEEE Journal of Biomedical and Health Informatics, 28(11), 6944–6957. https://doi.org/10.1109/JBHI.2024.3443137
Bai, B., Liu, X., & Li, H. (2026). Federated multimodal AI for precision-equitable diabetes care. Frontiers in Digital Health, 7, 1678047. https://doi.org/10.3389/fdgth.2025.1678047
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mateusz Kaczmarski, Paweł Kamiński, Laura Maria Surdacka-Barańska, Jakub Krzysztof Jagiełło, Adam Jakubas, Karolina Iwanicka, Karolina Pawelec, Sabina Maria Jóźwiak
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
